Michael A. Reid

Michael A. Reid

Auto-generated profile, based on publicly available information

Michael A. Reid

Department of Pharmacology and Cancer Biology, Duke University School of Medicine, Durham, USA

Research Focus & Metrics

Academic Career Length

36Years (1991-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 January 2015 in Nature Cell Biology
Verified
Journal Article
Open access
PDF file
MFMiranda Y. Fong
Miranda Y. Fong
WZWeiying Zhou
Weiying Zhou
LLLiang Liu
Liang Liu
AAAileen Y. Alontaga
Aileen Y. Alontaga
MCManasa Chandra
Manasa Chandra
Shizhen (Emily) WangShizhen (Emily) Wang
Shizhen (Emily) Wang
Reprogrammed glucose metabolism as a result of increased glycolysis and glucose uptake is a hallmark of cancer. Here we show that cancer cells can suppress glucose uptake by non-tumour cells in the premetastatic niche, by secreting vesicles that carry high levels of the miR-122 microRNA. High miR-122 levels in the circulation have been associated with metastasis in breast cancer patients, and we show that cancer-cell-secreted miR-122 facilitates metastasis by increasing nutrient availability in the premetastatic niche. Mechanistically, cancer-cell-derived miR-122 suppresses glucose uptake by niche cells in vitro and in vivo by downregulating the glycolytic enzyme pyruvate kinase. In vivo inhibition of miR-122 restores glucose uptake in distant organs, including brain and lungs, and decreases the incidence of metastasis. These results demonstrate that, by modifying glucose utilization by recipient premetastatic niche cells, cancer-derived extracellular miR-122 is able to reprogram systemic energy metabolism to facilitate disease progression.

23 October 2017 in Nature Cell Biology
Verified
Journal Article
Closed access
PDF file
MRMichael A. Reid
Michael A. Reid
ZDZiwei Dai
Ziwei Dai
JLJason W. Locasale
Jason W. Locasale

1 October 2018 in Cell
Verified
Journal Article
Closed access
XLXiaojing Liu
Xiaojing Liu
DCDaniel E. Cooper
Daniel E. Cooper
ACAhmad A. Cluntun
Ahmad A. Cluntun
MWMarc O. Warmoes
Marc O. Warmoes
SZSteven Zhao
Steven Zhao
JLJason W. Locasale
Jason W. Locasale

12 September 2016 in Nature Cell Biology
Verified
Journal Article
Closed access
PDF file
MPMin Pan
Min Pan
MRMichael A. Reid
Michael A. Reid
XLXazmin H. Lowman
Xazmin H. Lowman
RKRajan P. Kulkarni
Rajan P. Kulkarni
TTThai Q. Tran
Thai Q. Tran
MKMei Kong
Mei Kong

1 March 2018 in Cell Reports
Verified
Journal Article
Open access
XGXia Gao
Xia Gao
KLKatie Lee
Katie Lee
MRMichael A. Reid
Michael A. Reid
SSSydney M. Sanderson
Sydney M. Sanderson
CQChuping Qiu
Chuping Qiu
JLJason W. Locasale
Jason W. Locasale
Cell proliferation can be dependent on the non-essential amino acid serine, and dietary restriction of serine inhibits tumor growth, but the underlying mechanisms remain incompletely understood. Using a metabolomics approach, we found that serine deprivation most predominantly impacts cellular acylcarnitine levels, a signature of altered mitochondrial function. Fuel utilization from fatty acid, glucose, and glutamine is affected by serine deprivation, as are mitochondrial morphological dynamics leading to increased fragmentation. Interestingly, these changes can occur independently of nucleotide and redox metabolism, two known major functions of serine. A lipidomics analysis revealed an overall decrease in ceramide levels. Importantly, supplementation of the lipid component of bovine serum or C16:0-ceramide could partially restore defects in cell proliferation and mitochondrial fragmentation induced by serine deprivation. Together, these data define a role for serine in supporting mitochondrial function and cell proliferation through ceramide metabolism.

21 December 2018 in Nature Communications
Verified
Journal Article
Open access
PDF file
MRMichael A. Reid
Michael A. Reid
AAAnnamarie E. Allen
Annamarie E. Allen
SLShiyu Liu
Shiyu Liu
MLMaria V. Liberti
Maria V. Liberti
PLPei Liu
Pei Liu
JLJason W. Locasale
Jason W. Locasale
Phosphoglycerate dehydrogenase (PHGDH) catalyzes the committed step in de novo serine biosynthesis. Paradoxically, PHGDH and serine synthesis are required in the presence of abundant environmental serine even when serine uptake exceeds the requirements for nucleotide synthesis. Here, we establish a mechanism for how PHGDH maintains nucleotide metabolism. We show that inhibition of PHGDH induces alterations in nucleotide metabolism independent of serine utilization. These changes are not attributable to defects in serine-derived nucleotide synthesis and redox maintenance, another key aspect of serine metabolism, but result from disruption of mass balance within central carbon metabolism. Mechanistically, this leads to simultaneous alterations in both the pentose phosphate pathway and the tri-carboxylic acid cycle, as we demonstrate based on a quantitative model. These findings define a mechanism whereby disruption of one metabolic pathway induces toxicity by simultaneously affecting the activity of multiple related pathways.